DHANIRA
LIVE

Serial Number

99436297

Owner

Kiniksa Pharmaceuticals, GmbH

Attorney

Maury M. Tepper, III

Filing Date

Oct 10, 2025

Add to watchlist:

No watchlists yet
View on USPTO

DHANIRA Trademark

Serial Number: 99436297

DHANIRA is a trademark filed by Kiniksa Pharmaceuticals, GmbH on October 10, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Kiniksa Pharmaceuticals, GmbH (8 trademarks)

Grafenaustrasse 5
Zug 6302 , CH

Entity Type: 99

Trademark Details

Filing Date

October 10, 2025

Registration Date

Not Registered

Published for Opposition

May 5, 2026

Goods & Services

Anti-inflammatories; Cardiovascular pharmaceuticals; Pharmaceutical preparations for the treatment and prevention of inflammatory diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment and prevention of cardiac diseases and disorders; Pharmaceutical preparations for the treatment and prevention of immune-mediated diseases and disorders; Pharmaceutical preparations for the treatment and prevention of rare diseases and disorders

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 5, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 5, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 29, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 3, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 10, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 10, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 10, 2026 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 2, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 2, 2026 GNSL
SUSPENSION LETTER WRITTEN
Mar 2, 2026 CNSL
ASSIGNED TO EXAMINER
Feb 27, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 10, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Oct 10, 2025 MAFR
NEW APPLICATION ENTERED
Oct 10, 2025 NWAP